Baudax Bioinc Stock Z Score
| BXRX Stock | USD 0.01 0.0004 3.64% |
Baudax | Z Score |
Baudax BioInc Company Z Score Analysis
Baudax BioInc's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Baudax Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Baudax BioInc is extremely important. It helps to project a fair market value of Baudax Stock properly, considering its historical fundamentals such as Z Score. Since Baudax BioInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Baudax BioInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Baudax BioInc's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
In accordance with the company's disclosures, Baudax BioInc has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Baudax Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Baudax BioInc's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Baudax BioInc could also be used in its relative valuation, which is a method of valuing Baudax BioInc by comparing valuation metrics of similar companies.Baudax BioInc is currently under evaluation in z score category among related companies.
Baudax BioInc Institutional Holders
Institutional Holdings refers to the ownership stake in Baudax BioInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Baudax BioInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Baudax BioInc's value.| Shares | Virtu Financial Llc | 2023-12-31 | 0.0 | Sittner & Nelson, Llc | 2023-09-30 | 0.0 | Blackrock Inc | 2023-12-31 | 0.0 | Advisor Group Holdings, Inc. | 2023-12-31 | 0.0 | Xtx Topco Ltd | 2023-12-31 | 0.0 | Creative Planning Inc | 2023-09-30 | 0.0 | State Street Corporation | 2023-12-31 | 0.0 | Susquehanna International Group, Llp | 2023-12-31 | 0.0 | Wells Fargo & Co | 2023-12-31 | 0.0 | Jane Street Group, Llc | 2023-09-30 | 0.0 | Tower Research Capital Llc | 2023-12-31 | 0.0 |
Baudax Fundamentals
| Return On Equity | -47.04 | ||||
| Return On Asset | -1.15 | ||||
| Operating Margin | (27.60) % | ||||
| Current Valuation | 17.72 M | ||||
| Shares Outstanding | 43.59 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 2.68 % | ||||
| Number Of Shares Shorted | 493.56 K | ||||
| Price To Earning | 0.03 X | ||||
| Price To Book | 0.68 X | ||||
| Price To Sales | 0.75 X | ||||
| Revenue | 1.27 M | ||||
| Gross Profit | (5.74 M) | ||||
| EBITDA | (34.76 M) | ||||
| Net Income | (7.15 M) | ||||
| Cash And Equivalents | 5.65 M | ||||
| Cash Per Share | 0.28 X | ||||
| Total Debt | 7.12 M | ||||
| Debt To Equity | 2.26 % | ||||
| Current Ratio | 0.53 X | ||||
| Book Value Per Share | (0.84) X | ||||
| Cash Flow From Operations | (14.31 M) | ||||
| Short Ratio | 0.19 X | ||||
| Earnings Per Share | (94.13) X | ||||
| Target Price | 24.0 | ||||
| Beta | 1.58 | ||||
| Market Capitalization | 950.33 K | ||||
| Total Asset | 10.03 M | ||||
| Retained Earnings | (190.9 M) | ||||
| Working Capital | (15.11 M) | ||||
| Current Asset | 21.72 M | ||||
| Current Liabilities | 7.92 M | ||||
| Net Asset | 10.03 M |
About Baudax BioInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Baudax BioInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baudax BioInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baudax BioInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Baudax BioInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Baudax BioInc's short interest history, or implied volatility extrapolated from Baudax BioInc options trading.
Pair Trading with Baudax BioInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Baudax BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baudax BioInc will appreciate offsetting losses from the drop in the long position's value.Moving against Baudax Stock
| 0.81 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.64 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.61 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.59 | ZNTL | Zentalis PharmaceuticalsL Buyout Trend | PairCorr |
| 0.5 | MRSN | Mersana Therapeutics Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Baudax BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Baudax BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Baudax BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Baudax BioInc to buy it.
The correlation of Baudax BioInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Baudax BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Baudax BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Baudax BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Baudax BioInc Piotroski F Score and Baudax BioInc Valuation analysis. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Baudax Stock analysis
When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.13) | Revenue Per Share 0.318 | Quarterly Revenue Growth (0.23) | Return On Assets (1.15) | Return On Equity (47.04) |
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.